154 related articles for article (PubMed ID: 33794821)
21. High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa.
Chachage M; Parikh AP; Mahenge A; Bahemana E; Mnkai J; Mbuya W; Mcharo R; Maganga L; Mwamwaja J; Gervas R; Kibuuka H; Maswai J; Singoei V; Iroezindu M; Fasina A; Esber A; Dear N; Imbach M; Crowell TA; Hern J; Song X; Hoelscher M; Polyak CS; Ake JA; Geldmacher C;
AIDS; 2023 Mar; 37(4):625-635. PubMed ID: 36398743
[TBL] [Abstract][Full Text] [Related]
22. Low uptake of cervical cancer screening among HIV positive women in Gondar University referral hospital, Northwest Ethiopia: cross-sectional study design.
Nega AD; Woldetsadik MA; Gelagay AA
BMC Womens Health; 2018 Jun; 18(1):87. PubMed ID: 29879969
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.
Rohner E; Sengayi M; Goeieman B; Michelow P; Firnhaber C; Maskew M; Bohlius J
Int J Cancer; 2017 Aug; 141(3):488-496. PubMed ID: 28440019
[TBL] [Abstract][Full Text] [Related]
24. Veteran Women Living With Human Immunodeficiency Virus Have Increased Risk of Human Papillomavirus (HPV)-Associated Genital Tract Cancers.
Clark E; Chen L; Dong Y; Raychaudhury S; White D; Kramer JR; Chiao E
Clin Infect Dis; 2021 May; 72(9):e359-e366. PubMed ID: 32785700
[TBL] [Abstract][Full Text] [Related]
25. Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment.
Carlander C; Lagheden C; Eklund C; Nordqvist Kleppe S; Dzabic M; Wagner P; Sparén P; Dillner J
AIDS; 2021 Nov; 35(14):2367-2374. PubMed ID: 34723851
[TBL] [Abstract][Full Text] [Related]
26. Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
Magaji FA; Mashor MI; Anzaku SA; Hinjari AR; Cosmas NT; Kwaghe BV; Ali JM; Christian EN; Sagay AS; Chandler A; Khan I; Murphy RL; Hou L; Musa J
BMC Public Health; 2024 Jan; 24(1):193. PubMed ID: 38229083
[TBL] [Abstract][Full Text] [Related]
27. "My husband says this: If you are alive, you can be someone…": Facilitators and barriers to cervical cancer screening among women living with HIV in India.
Kung TH; Gordon JR; Abdullahi A; Barve A; Chaudhari V; Kosambiya JK; Kumar A; Gamit S; Wells KJ
Cancer Causes Control; 2019 Apr; 30(4):365-374. PubMed ID: 30809741
[TBL] [Abstract][Full Text] [Related]
28. Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities, Hawassa town, Ethiopia: a cross-sectional study.
Assefa AA; Astawesegn FH; Eshetu B
BMC Health Serv Res; 2019 Nov; 19(1):847. PubMed ID: 31744548
[TBL] [Abstract][Full Text] [Related]
29. Utilization of Pap testing among women living with HIV enrolled in primary care in Baltimore, Maryland: A 10-year longitudinal study, 2005-2014.
Peprah S; Coleman JS; Rositch AF; Vanden Bussche CJ; Moore R; D'Souza G
Papillomavirus Res; 2018 Dec; 6():52-57. PubMed ID: 30420338
[TBL] [Abstract][Full Text] [Related]
30. Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000-2020).
Yang L; Boily MC; Rönn MM; Obiri-Yeboah D; Morhason-Bello I; Meda N; Lompo O; Mayaud P; Pickles M; Brisson M; Hodgins C; Delany-Moretlwe S; Maheu-Giroux M
PLoS Med; 2023 Jan; 20(1):e1004143. PubMed ID: 36634119
[TBL] [Abstract][Full Text] [Related]
31. Cervical testing beyond the screening target age - A register-based cohort study from Finland.
Keltto N; Leivonen A; Pankakoski M; Sarkeala T; Heinävaara S; Anttila A
Gynecol Oncol; 2021 Aug; 162(2):315-321. PubMed ID: 34074539
[TBL] [Abstract][Full Text] [Related]
32. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
Nowakowski A; Cybulski M; Śliwczyński A; Chil A; Teter Z; Seroczyński P; Arbyn M; Anttila A
BMC Cancer; 2015 Apr; 15():279. PubMed ID: 25879466
[TBL] [Abstract][Full Text] [Related]
33. HPV Types in Cervical Precancer by HIV Status and Birth Region: A Population-Based Register Study.
Carlander C; Lagheden C; Eklund C; Nordqvist Kleppe S; Dzabic M; Wagner P; Yilmaz A; Elfgren K; Sönnerborg A; Sparén P; Dillner J
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2662-2668. PubMed ID: 32967862
[TBL] [Abstract][Full Text] [Related]
34. Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK.
Cicconi P; Wells C; McCarthy B; Wareing S; Andersson MI; Fox J; Lwanga J; Pal N; Burns F; Woodward C; Malek R; Sabin CA; Dorrell L
HIV Med; 2022 Apr; 23(4):390-396. PubMed ID: 35243750
[TBL] [Abstract][Full Text] [Related]
35. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study.
Msyamboza KP; Phiri T; Sichali W; Kwenda W; Kachale F
BMC Public Health; 2016 Aug; 16(1):806. PubMed ID: 27535359
[TBL] [Abstract][Full Text] [Related]
37. Primary HPV and Molecular Cervical Cancer Screening in US Women Living With Human Immunodeficiency Virus.
Strickler HD; Keller MJ; Hessol NA; Eltoum IE; Einstein MH; Castle PE; Massad LS; Flowers L; Rahangdale L; Atrio JM; Ramirez C; Minkoff H; Adimora AA; Ofotokun I; Colie C; Huchko MJ; Fischl M; Wright R; D'Souza G; Leider J; Diaz O; Sanchez-Keeland L; Shrestha S; Xie X; Xue X; Anastos K; Palefsky JM; Burk RD
Clin Infect Dis; 2021 May; 72(9):1529-1537. PubMed ID: 32881999
[TBL] [Abstract][Full Text] [Related]
38. Distribution of cervical abnormalities detected by visual inspection with acetic acid in Swaziland, 2011-2014: A retrospective study.
Ginindza TG; Almonte M; Dlamini X; Sartorius B
Afr J Prim Health Care Fam Med; 2018 Oct; 10(1):e1-e7. PubMed ID: 30456977
[TBL] [Abstract][Full Text] [Related]
39. A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: Implications for prevention strategies.
Zhao R; Sekar P; Bennis SL; Kulasingam S
Prev Med; 2023 May; 170():107494. PubMed ID: 37001607
[TBL] [Abstract][Full Text] [Related]
40. Determinants of Cervical Cancer Screening Service Utilization Among HIV-Positive Women Aged 25 Years and Above Attending Adult ART Clinics in Southern Tigray, Ethiopia.
Gebrekirstos LG; Gebremedhin MH; Tafesse TT; Tura TS; Geleso MG; Wube TB
Cancer Control; 2022; 29():10732748221126944. PubMed ID: 36112936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]